LAS VEGAS, Nevada — The Cleveland Clinic Lou Ruvo Center for Brain Health will accept its first patients today.
The highly specialized clinical center will aim at advancing research, early detection and treatment of neurological diseases, according to the Cleveland Clinic, which in February agreed to staff and manage the center. Diseases to be treated include Alzheimer’s, Huntington’s, Parkinson’s and Amyotrophic Lateral Sclerosis, sometimes called Lou Gehrig’s disease.
Las Vegas businessman and philanthropist Larry Ruvo began planning the center after his father, Lou Ruvo, died in 1994, a victim of Alzheimer’s disease. Larry Ruvo wanted to create a cognitive disease centerwhere compassionate care would go hand-in-hand with cutting-edge treatments, and sophisticated research would be combined with education for caregivers.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“We still have much more to accomplish, but welcoming patients is a truly significant benchmark for us,” Larry Ruvo said in a Cleveland Clinic release.
Ruvo enlisted well-known architect Frank Gehry to design the $100 million brain center, which houses clinical space, a diagnostic center, neuro-imaging rooms, phsyicians’ offices and laboratories dedicated to clinical research, the Clinic said.Â
The center’s mission is to prevent the chronic symptoms of disabling brain diseases and to prolong healthy aging among people who are at risk for cognitive disorders or dementia. The center will follow the Clinic’s “institute” model, which pools and links medical experts across clinical disciplines and research areas to provide the best care for patients. Â
“Applying our model of care to the treatment of cognitive disorders promises to improve the quality of life for countless Americans,” said Dr. Toby Cosgrove, the Clinic’s chief executive and president, in the statement. “By integrating clinical care, research and prevention under one roof, we can streamline and improve care for our patients.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Dr. Randolph Schiffer, formerly the Vernon and Elizabeth Haggerton Chair in Neurology at the Clinic, will lead the new brain center. Dr. Charles Bernick, a neurologist who has more than two decades’ experience in treating Alzheimer’s, is joining Schiffer.
“Larry Shuvo has done it, he truly is the American story,” said U.S. Sen. Harry Reid in the release. “He has brought the reputation of a first-class facility, one of the most famous architects of our time and now one of the five best medical institutions in the world to Nevada.”
